Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans
- PMID: 24859635
- PMCID: PMC4095745
- DOI: 10.1016/j.atherosclerosis.2014.04.035
Significant associations between lipoprotein(a) and corrected apolipoprotein B-100 levels in African-Americans
Abstract
Objectives: Lipoprotein(a), Lp(a), represents an apolipoprotein (apo) B-carrying lipoprotein, yet the relationship between Lp(a) and apoB levels has not been fully explored.
Methods: We addressed the relationship between Lp(a) and apoB-containing lipoprotein levels in 336 Caucasians and 224 African-Americans. Our approach takes unique molecular properties of Lp(a) as well as contribution of Lp(a) to the levels of these lipoproteins into account.
Results: Levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apoB and apoB/apoA-1 did not differ across ethnicity. African-Americans had higher levels of Lp(a) and high-density lipoprotein cholesterol and lower triglyceride levels compared to Caucasians. Lp(a) levels were correlated with levels of TC (p < 0.005), LDL-C (p < 0.001), apoB (p < 0.05) or apoB/apoA-1 (p < 0.05) in both ethnic groups. These associations remained significant only in African-Americans after adjustments for the contribution of Lp(a)-cholesterol or Lp(a)-apoB. Furthermore, taking Lp(a)-apoB into account, allele-specific apo(a) levels were significantly associated with apoB levels and the apoB/apoA-1 ratio in African-Americans. The latter associations in African-Americans remained significant for allele-specific apo(a) levels for smaller apo(a) sizes (<26 K4 repeats), after controlling for the effects of age, sex, and BMI.
Conclusions: Although TC, LDL-C, and apoB levels were comparable between African-Americans and Caucasians, the associations of these parameters with Lp(a) and allele specific apo(a) levels differed between these two ethnic groups. In African-Americans, apoB and apoB/apoA-1 remained consistently and positively associated with both Lp(a) and allele-specific apo(a) levels after adjustments for the contribution of Lp(a)-apoB. The findings suggest an interethnic difference with a closer relationship between Lp(a) and apoB among African-Americans.
Keywords: Apo(a) sizes; Corrections for the contribution of Lp(a); Ethnicity; K4 repeats; Plasma lipids.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.
Figures


Similar articles
-
Association of Lp-PLA(2) activity with allele-specific Lp(a) levels in a bi-ethnic population.Atherosclerosis. 2010 Aug;211(2):526-30. doi: 10.1016/j.atherosclerosis.2010.03.021. Epub 2010 Apr 20. Atherosclerosis. 2010. PMID: 20444451 Free PMC article.
-
Differential associations of serum amyloid A and pentraxin-3 with allele-specific lipoprotein(a) levels in African Americans and Caucasians.Transl Res. 2011 Aug;158(2):92-8. doi: 10.1016/j.trsl.2011.01.004. Epub 2011 Feb 5. Transl Res. 2011. PMID: 21757153 Free PMC article.
-
Relationship of oxidized phospholipids on apolipoprotein B-100 particles to race/ethnicity, apolipoprotein(a) isoform size, and cardiovascular risk factors: results from the Dallas Heart Study.Circulation. 2009 Apr 7;119(13):1711-9. doi: 10.1161/CIRCULATIONAHA.108.836940. Epub 2009 Mar 23. Circulation. 2009. PMID: 19307470 Free PMC article.
-
Lipoprotein(a) as an Old and New Causal Risk Factor of Atherosclerotic Cardiovascular Disease.J Atheroscler Thromb. 2019 Jul 1;26(7):583-591. doi: 10.5551/jat.RV17034. Epub 2019 Apr 30. J Atheroscler Thromb. 2019. PMID: 31061262 Free PMC article. Review.
-
Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.Biomark Med. 2011 Oct;5(5):673-94. doi: 10.2217/bmm.11.60. Biomark Med. 2011. PMID: 22003918 Free PMC article. Review.
Cited by
-
Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?Nutrients. 2020 Jul 7;12(7):2024. doi: 10.3390/nu12072024. Nutrients. 2020. PMID: 32646066 Free PMC article. Review.
-
Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics.Cardiovasc Res. 2022 Mar 25;118(5):1218-1231. doi: 10.1093/cvr/cvab100. Cardiovasc Res. 2022. PMID: 33769464 Free PMC article. Review.
-
Lipoprotein(a) and the Apolipoprotein B/A1 Ratio Independently Associate With Surgery for Aortic Stenosis Only in Patients With Concomitant Coronary Artery Disease.J Am Heart Assoc. 2017 Dec 15;6(12):e007160. doi: 10.1161/JAHA.117.007160. J Am Heart Assoc. 2017. PMID: 29246959 Free PMC article. Clinical Trial.
-
Is the ratio of apoB/apoA-1 the best predictor for the severity of coronary artery lesions in Chinese diabetics with stable angina pectoris? An assessment based on Gensini scores.J Geriatr Cardiol. 2015 Jul;12(4):402-9. doi: 10.11909/j.issn.1671-5411.2015.04.012. J Geriatr Cardiol. 2015. PMID: 26346771 Free PMC article.
-
Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target.Metabolites. 2021 Oct 8;11(10):690. doi: 10.3390/metabo11100690. Metabolites. 2021. PMID: 34677405 Free PMC article. Review.
References
-
- Kamstrup PR, Tybjaerg-Hansen A, Steffensen R, et al. Genetically elevated lipoprotein(a) and increased risk of myocardial infarction. JAMA. 2009;301:2331–9. - PubMed
-
- Clarke R, Peden JF, Hopewell JC, et al. Genetic variants associated with Lp(a) lipoprotein level and coronary disease. N Engl J Med. 2009;361:2518–28. - PubMed
-
- McLean JW, Tomlinson JE, Kuang WJ, et al. cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature. 1987;330:132–7. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous